Search research articles
Contact Us
Filters
Showing results (131-140 of 146) with videos related to
Page
of 15
Sort By:
Infection and Immunity
|
August 1, 1992
Interaction of capsulate Haemophilus influenzae with human airway mucosa in vitro
R C Read, A A Rutman, P K Jeffery, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 1, 2014
MBL2 deficiency is associated with higher genomic bacterial loads during meningococcemia in young children
T C Darton, D L Jack, M Johnson, et al.
The Journal of Infectious Diseases
|
October 7, 2000
An interleukin-1 genotype is associated with fatal outcome of meningococcal disease
R C Read, N J Camp, F S di Giovine, et al.
The Journal of Infectious Diseases
|
August 9, 2001
A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease
R C Read, J Pullin, S Gregory, et al.
Health Technology Assessment (Winchester, England)
|
October 7, 2010
Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings
B Killingley, J Greatorex, S Cauchemez, et al.
JAMA
|
November 7, 1990
Intrapleural tetracycline for the prevention of recurrent spontaneous pneumothorax. Results of a Department of Veterans Affairs cooperative study
R W Light, V S O'Hara, T E Moritz, et al.
The Annals of Thoracic Surgery
|
August 1, 1993
Thromboembolism in patients undergoing thoracotomy
S Ziomek, R C Read, H G Tobler, et al.
American Journal of Surgery
|
August 1, 1994
Isolated symptomatic midcervical stenosis of the internal carotid artery
T J Ranval, M M Solis, R W Barnes, et al.
Health Technology Assessment (Winchester, England)
|
January 7, 2011
A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apart
K G Nicholson, K R Abrams, S Batham, et al.
Thorax
|
July 15, 2010
Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009)
J S Nguyen-Van-Tam, P J M Openshaw, A Hashim, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 146) with videos related to
Sort By:
Page
of 15
Infection and Immunity
|
August 1, 1992
Interaction of capsulate Haemophilus influenzae with human airway mucosa in vitro
R C Read, A A Rutman, P K Jeffery, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 1, 2014
MBL2 deficiency is associated with higher genomic bacterial loads during meningococcemia in young children
T C Darton, D L Jack, M Johnson, et al.
The Journal of Infectious Diseases
|
October 7, 2000
An interleukin-1 genotype is associated with fatal outcome of meningococcal disease
R C Read, N J Camp, F S di Giovine, et al.
The Journal of Infectious Diseases
|
August 9, 2001
A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease
R C Read, J Pullin, S Gregory, et al.
Health Technology Assessment (Winchester, England)
|
October 7, 2010
Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings
B Killingley, J Greatorex, S Cauchemez, et al.
JAMA
|
November 7, 1990
Intrapleural tetracycline for the prevention of recurrent spontaneous pneumothorax. Results of a Department of Veterans Affairs cooperative study
R W Light, V S O'Hara, T E Moritz, et al.
The Annals of Thoracic Surgery
|
August 1, 1993
Thromboembolism in patients undergoing thoracotomy
S Ziomek, R C Read, H G Tobler, et al.
American Journal of Surgery
|
August 1, 1994
Isolated symptomatic midcervical stenosis of the internal carotid artery
T J Ranval, M M Solis, R W Barnes, et al.
Health Technology Assessment (Winchester, England)
|
January 7, 2011
A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apart
K G Nicholson, K R Abrams, S Batham, et al.
Thorax
|
July 15, 2010
Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009)
J S Nguyen-Van-Tam, P J M Openshaw, A Hashim, et al.
Page
of 15